MARKET

IBIO

IBIO

Ibio
NASDAQ
1.610
-0.050
-3.01%
Pre Market: 1.660 +0.05 +3.11% 04:39 05/13 EDT
OPEN
1.660
PREV CLOSE
1.660
HIGH
1.670
LOW
1.590
VOLUME
132
TURNOVER
0
52 WEEK HIGH
3.820
52 WEEK LOW
0.5562
MARKET CAP
58.19M
P/E (TTM)
-1.2789
1D
5D
1M
3M
1Y
5Y
1D
BRIEF-Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update
Reuters · 12h ago
iBio reports Q3 EPS (7c), consensus (6c)
TipRanks · 12h ago
iBio Q3 EPS $(0.07) Misses $(0.06) Estimate
Benzinga · 13h ago
iBio wins Australian clearance to start Phase 1 trial of obesity drug IBIO-600
PUBT · 13h ago
*IBio Extends Cash Runway Into 4Q of Fiscal Yr 2028
Dow Jones · 13h ago
IBIO INC: QTRLY LOSS PER SHARE $-0.07
Reuters · 14h ago
Press Release: iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
Dow Jones · 14h ago
Press Release: iBio Reports Q3 Fiscal Year 2026 -2-
Dow Jones · 14h ago
More
About IBIO
iBio, Inc. is a biotech company leveraging artificial intelligence and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with drug discovery platforms, it is creating a pipeline of antibody treatments to address significant unmet medical needs. Its proprietary StableHu technology is instrumental in this optimization process. StableHu is an AI- powered tool designed to predict a library of antibodies with fully human CDR variants based on an input antibody. It has a pipeline of pre-clinical programs with differentiated profiles and high potential impact, including IBIO-101, its second-generation anti-CD25 monoclonal antibody, a TROP-2 x CD3 bispecific antibody, an antibody that binds to a non-shed, non-glycosylated region of MUC16, an antibody that binds to an epitope on EGFRvIII without binding wildtype EGFR, and an anti-CCR8 antibody.

Webull offers Ibio Inc stock information, including NASDAQ: IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.